CMAB Biopharma Secures $34 Million Series B Financing
SUZHOU, China, April 02, 2018 (GLOBE NEWSWIRE) -- CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for biologic products, today announced that …